Philip Eliades

746 total citations
12 papers, 481 citations indexed

About

Philip Eliades is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Philip Eliades has authored 12 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Philip Eliades's work include Cutaneous Melanoma Detection and Management (6 papers), Melanoma and MAPK Pathways (5 papers) and Skin Protection and Aging (2 papers). Philip Eliades is often cited by papers focused on Cutaneous Melanoma Detection and Management (6 papers), Melanoma and MAPK Pathways (5 papers) and Skin Protection and Aging (2 papers). Philip Eliades collaborates with scholars based in United States, South Korea and Greece. Philip Eliades's co-authors include Hensin Tsao, Mi Ryung Roh, Sameer Gupta, Efthymia Soura, Alexander Stratigos, Kristen Shannon, Jane M. Grant‐Kels, Shaoping Deng, Heidi Yeh and James F. Markmann and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Investigative Dermatology and Journal of the American Academy of Dermatology.

In The Last Decade

Philip Eliades

12 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Eliades United States 9 245 193 121 88 67 12 481
Erica Riveiro‐Falkenbach Spain 10 192 0.8× 362 1.9× 94 0.8× 55 0.6× 53 0.8× 25 575
Aimee L Leonard United States 8 173 0.7× 169 0.9× 79 0.7× 43 0.5× 98 1.5× 16 433
Janet L. Maldonado United States 5 438 1.8× 488 2.5× 99 0.8× 108 1.2× 90 1.3× 6 714
Li Fu China 11 327 1.3× 200 1.0× 245 2.0× 72 0.8× 20 0.3× 18 628
Liang-Ping Xia China 9 181 0.7× 206 1.1× 48 0.4× 102 1.2× 22 0.3× 13 424
Tousei Ohmura Japan 10 176 0.7× 336 1.7× 73 0.6× 56 0.6× 15 0.2× 17 494
Gabriela Turcu Romania 10 288 1.2× 117 0.6× 174 1.4× 34 0.4× 38 0.6× 26 463
Gregory Khitrov United States 7 72 0.3× 279 1.4× 46 0.4× 90 1.0× 54 0.8× 10 590
Jian‐Zhong Qin United States 8 224 0.9× 479 2.5× 120 1.0× 80 0.9× 27 0.4× 8 641
Claudia H.D. Metz Germany 10 290 1.2× 375 1.9× 228 1.9× 62 0.7× 13 0.2× 15 836

Countries citing papers authored by Philip Eliades

Since Specialization
Citations

This map shows the geographic impact of Philip Eliades's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Eliades with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Eliades more than expected).

Fields of papers citing papers by Philip Eliades

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Eliades. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Eliades. The network helps show where Philip Eliades may publish in the future.

Co-authorship network of co-authors of Philip Eliades

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Eliades. A scholar is included among the top collaborators of Philip Eliades based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Eliades. Philip Eliades is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Eliades, Philip, et al.. (2020). Use of Etanercept in a Series of Pediatric Patients With Stevens-Johnson Syndrome–Toxic Epidermal Necrolysis Spectrum Disease. JAMA Dermatology. 156(8). 921–921. 11 indexed citations
2.
Eliades, Philip, Brian J. Abraham, Zhenyu Ji, et al.. (2018). High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma. Journal of Investigative Dermatology. 138(7). 1582–1590. 42 indexed citations
3.
Roh, Mi Ryung, Philip Eliades, Sameer Gupta, Jane M. Grant‐Kels, & Hensin Tsao. (2017). Cutaneous melanoma in women. International Journal of Women’s Dermatology. 3(1). S11–S15. 33 indexed citations
4.
Eliades, Philip, David M. Miller, Benchun Miao, et al.. (2016). A novel multi-CDK inhibitor P1446A-05 restricts melanoma growth and produces synergistic effects in combination with MAPK pathway inhibitors. Cancer Biology & Therapy. 17(7). 778–784. 8 indexed citations
5.
Soura, Efthymia, Philip Eliades, Kristen Shannon, Alexander Stratigos, & Hensin Tsao. (2016). Hereditary melanoma: Update on syndromes and management. Journal of the American Academy of Dermatology. 74(3). 411–420. 47 indexed citations
6.
Soura, Efthymia, Philip Eliades, Kristen Shannon, Alexander Stratigos, & Hensin Tsao. (2016). Hereditary melanoma: Update on syndromes and management. Journal of the American Academy of Dermatology. 74(3). 395–407. 121 indexed citations
7.
Roh, Mi Ryung, Philip Eliades, Sameer Gupta, Jane M. Grant‐Kels, & Hensin Tsao. (2015). Cutaneous melanoma in women. SHILAP Revista de lepidopterología. 1(1). 21–25. 10 indexed citations
9.
Eliades, Philip, Keith T. Flaherty, & Hensin Tsao. (2015). Oncogene-Directed Small Molecule Inhibitors for the Treatment of Cutaneous Melanoma. PubMed. 2(2). 133–147. 3 indexed citations
10.
Roh, Mi Ryung, Philip Eliades, Sameer Gupta, & Hensin Tsao. (2015). Genetics of melanocytic nevi. Pigment Cell & Melanoma Research. 28(6). 661–672. 100 indexed citations
11.
Kim, Jong‐Il, Ryan Stott, Heidi Yeh, et al.. (2012). Anti-CD45RB/Anti-TIM-1-Induced Tolerance Requires Regulatory B Cells. American Journal of Transplantation. 12(8). 2072–2078. 89 indexed citations
12.
Kim, James I., Gaoping Zhao, Kang Mi Lee, et al.. (2011). Generation of Adaptive Regulatory T Cells by Alloantigen Is Required for Some But Not All Transplant Tolerance Protocols. Transplantation. 91(7). 707–713. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026